Annual Cash & Cash Equivalents:
$302.08M+$101.73M(+50.77%)Summary
- As of today, WVE annual cash & cash equivalents is $302.08 million, with the most recent change of +$101.73 million (+50.77%) on December 31, 2024.
- During the last 3 years, WVE annual cash & cash equivalents has risen by +$151.51 million (+100.63%).
- WVE annual cash & cash equivalents is now at all-time high.
Performance
WVE Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$208.48M-$34.59M(-14.23%)Summary
- As of today, WVE quarterly cash & cash equivalents is $208.48 million, with the most recent change of -$34.59 million (-14.23%) on June 30, 2025.
- Over the past year, WVE quarterly cash & cash equivalents has increased by +$54.52 million (+35.41%).
- WVE quarterly cash & cash equivalents is now -32.95% below its all-time high of $310.95 million, reached on September 30, 2024.
Performance
WVE Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
WVE Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +50.8% | +35.4% |
| 3Y3 Years | +100.6% | +40.7% |
| 5Y5 Years | +105.3% | +121.7% |
WVE Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +241.3% | -33.0% | +135.6% |
| 5Y | 5-Year | at high | +241.3% | -33.0% | +135.6% |
| All-Time | All-Time | at high | >+9999.0% | -33.0% | >+9999.0% |
WVE Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $208.48M(-14.2%) |
| Mar 2025 | - | $243.07M(-19.5%) |
| Dec 2024 | $302.08M(+50.8%) | $302.08M(-2.9%) |
| Sep 2024 | - | $310.95M(+102.0%) |
| Jun 2024 | - | $153.96M(-14.9%) |
| Mar 2024 | - | $180.92M(-9.7%) |
| Dec 2023 | $200.35M(+126.4%) | $200.35M(+43.2%) |
| Sep 2023 | - | $139.94M(-19.1%) |
| Jun 2023 | - | $172.97M(-16.7%) |
| Mar 2023 | - | $207.56M(+134.5%) |
| Dec 2022 | $88.50M(-41.2%) | $88.50M(-27.5%) |
| Sep 2022 | - | $122.00M(-17.7%) |
| Jun 2022 | - | $148.16M(+32.6%) |
| Mar 2022 | - | $111.71M(-25.8%) |
| Dec 2021 | $150.56M(-18.4%) | $150.56M(+21.5%) |
| Sep 2021 | - | $123.90M(-13.9%) |
| Jun 2021 | - | $143.84M(-3.2%) |
| Mar 2021 | - | $148.53M(-19.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $184.50M(+25.4%) | $184.50M(-14.7%) |
| Sep 2020 | - | $216.36M(+130.0%) |
| Jun 2020 | - | $94.05M(-22.2%) |
| Mar 2020 | - | $120.95M(-28.2%) |
| Dec 2019 | $147.16M(-15.8%) | - |
| Dec 2018 | $174.82M(+22.7%) | - |
| Dec 2017 | $142.50M(-5.2%) | - |
| Sep 2017 | - | $168.46M(-14.7%) |
| Jun 2017 | - | $197.39M(+31.3%) |
| Dec 2016 | $150.29M(-6.8%) | $150.29M(-11.1%) |
| Sep 2016 | - | $169.01M(-7.0%) |
| Jun 2016 | - | $181.76M(+18.5%) |
| Mar 2016 | - | $153.40M(-4.9%) |
| Dec 2015 | $161.22M(>+9900.0%) | $161.22M(+144.1%) |
| Sep 2015 | - | $66.04M(+749.0%) |
| Jun 2015 | - | $7.78M(+642.3%) |
| Dec 2014 | $1.05M(+138.7%) | $1.05M |
| Dec 2013 | $439.00K | - |
FAQ
- What is Wave Life Sciences Ltd. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. annual cash & cash equivalents year-on-year change?
- What is Wave Life Sciences Ltd. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Wave Life Sciences Ltd.?
- What is Wave Life Sciences Ltd. quarterly cash & cash equivalents year-on-year change?
What is Wave Life Sciences Ltd. annual cash & cash equivalents?
The current annual cash & cash equivalents of WVE is $302.08M
What is the all-time high annual cash & cash equivalents for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high annual cash & cash equivalents is $302.08M
What is Wave Life Sciences Ltd. annual cash & cash equivalents year-on-year change?
Over the past year, WVE annual cash & cash equivalents has changed by +$101.73M (+50.77%)
What is Wave Life Sciences Ltd. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of WVE is $208.48M
What is the all-time high quarterly cash & cash equivalents for Wave Life Sciences Ltd.?
Wave Life Sciences Ltd. all-time high quarterly cash & cash equivalents is $310.95M
What is Wave Life Sciences Ltd. quarterly cash & cash equivalents year-on-year change?
Over the past year, WVE quarterly cash & cash equivalents has changed by +$54.52M (+35.41%)